It Should Not Be This Difficult to Engage Pharma in an Effective, Safe, Inexpensive Product for Acute Migraine, the Third Most Prevalent Disease in the World.
作者信息
Hagan John C
机构信息
Kansas City, Missouri, ophthalmologist and Missouri Medicine Editor since 2000. He is a multi-year Diamond Contributor to MMPAC.
出版信息
Mo Med. 2022 Jan-Feb;119(1):4-6.
Abstract
摘要
相似文献
1
2
Role of magnesium in the pathogenesis and treatment of migraine.镁在偏头痛发病机制及治疗中的作用。
Expert Rev Neurother. 2009 Mar;9(3):369-79. doi: 10.1586/14737175.9.3.369.
3
Galcanezumab effect on "whole pain burden" and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience.加巴喷丁治疗偏头痛患者的“整体疼痛负担”和多维结局的效果：真实世界的经验。
J Headache Pain. 2022 Jun 13;23(1):69. doi: 10.1186/s10194-022-01436-6.
4
Pharmacological synergy: the next frontier on therapeutic advancement for migraine.药物协同作用：偏头痛治疗进展的下一个前沿领域。
Headache. 2012 Apr;52(4):636-47. doi: 10.1111/j.1526-4610.2011.02058.x. Epub 2012 Jan 6.
5
Why all migraine patients should be treated with magnesium.为什么所有偏头痛患者都应该接受镁治疗。
J Neural Transm (Vienna). 2012 May;119(5):575-9. doi: 10.1007/s00702-012-0790-2. Epub 2012 Mar 18.
6
A Real-World Analysis of Patient Characteristics, Treatment Patterns, and Level of Impairment in Patients With Migraine Who are Insufficient Responders vs Responders to Acute Treatment.真实世界中偏头痛患者的特征、治疗模式和失能水平分析：急性治疗无应答者与应答者的比较。
Headache. 2020 Jul;60(7):1325-1339. doi: 10.1111/head.13835. Epub 2020 Jun 8.
7
[Argentinean consensus guidelines on the use of monoclonal antibodies in patients with migraine].[阿根廷关于偏头痛患者使用单克隆抗体的共识指南]
Rev Neurol. 2020 Feb 16;70(4):149-158. doi: 10.33588/rn.7004.2019399.
8
Cost considerations in headache treatment. Part 2: Acute migraine treatment.
Headache. 1996 Sep;36(8):493-502. doi: 10.1046/j.1526-4610.1996.3608493.x.
9
The effects of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-lowering and migraine disability.维生素补充剂和亚甲基四氢叶酸还原酶（C677T）基因型对降低同型半胱氨酸水平及偏头痛致残的影响
Pharmacogenet Genomics. 2009 Jun;19(6):422-8. doi: 10.1097/FPC.0b013e32832af5a3.
10
Medications Approved for Preventing Migraine Headaches.预防偏头痛的药物获批。
Am J Med. 2020 Jun;133(6):664-667. doi: 10.1016/j.amjmed.2020.01.031. Epub 2020 Mar 5.
引用本文的文献
1
Mixing It Up: The Art and Science of Compounding Pharmacy.混合调配：复方制药的艺术与科学
Mo Med. 2025 Mar-Apr;122(2):76-80.
2
Timolol 0.5% Eye Drops for Essential Tremor: First Successful Case Report.用于特发性震颤的0.5%噻吗洛尔滴眼液：首例成功病例报告。
Mo Med. 2024 Nov-Dec;121(6):464-466.
3
本文引用的文献
1
Short-term Efficacy and Safety of Topical β-Blockers (Timolol Maleate Ophthalmic Solution, 0.5%) in Acute Migraine: A Randomized Crossover Trial.局部β-阻滞剂（马来酸噻吗洛尔滴眼液，0.5%）治疗急性偏头痛的短期疗效和安全性：一项随机交叉试验。
JAMA Ophthalmol. 2020 Nov 1;138(11):1160-1166. doi: 10.1001/jamaophthalmol.2020.3676.
2
Put a Drop of Timolol Into Each Eye and Call Me in the Morning.每只眼睛滴一滴噻吗洛尔，明天早上给我打电话。
JAMA Ophthalmol. 2020 Nov 1;138(11):1166-1167. doi: 10.1001/jamaophthalmol.2020.3837.
3
Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality.
Int J Pharm Compd. 2020 May-Jun;24(3):194-197.
4
A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine.一项评估噻吗洛尔滴眼液作为偏头痛急性治疗药物的疗效和安全性的随机、双盲、安慰剂对照、交叉研究。
Kans J Med. 2020 Feb 26;13(Suppl 2):2-5. eCollection 2020.
5
Beta Blocker Eye Drops Have Dramatically Helped My Severe Migraines.β受体阻滞剂眼药水极大地缓解了我的严重偏头痛。
Mo Med. 2018 Nov-Dec;115(6):525.
6
Topical Beta Blockers for the Treatment of Acute Migraines in 2019.2019年用于治疗急性偏头痛的局部用β受体阻滞剂
Mo Med. 2018 Nov-Dec;115(6):522-524.
7
8
Timolol Eyedrops in the Treatment of Acute Migraine Attacks: A Randomized Crossover Study.噻吗洛尔滴眼液治疗急性偏头痛发作的随机交叉研究。
JAMA Neurol. 2018 Aug 1;75(8):1024-1025. doi: 10.1001/jamaneurol.2018.0970.
9
Can topical beta blockers be successful for acute migraine management?局部用β受体阻滞剂对急性偏头痛的治疗能成功吗？
Mo Med. 2014 Jul-Aug;111(4):294-6.
10
Ophthalmic beta blockers: treatment for acute migraine?眼科用β受体阻滞剂：用于治疗急性偏头痛？
Mo Med. 2014 Jul-Aug;111(4):292-3.
Zotero 插件